Evidence map›Paper›PMID 34605022›Full record

ArticleInternational journal of cancer2022

Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.

Femmie de Vegt, Jessie J J Gommers, Hans Groenewoud, Peter D Siersema, André L M Verbeek, Yonne Peters, Mireille J M Broeders

Abstract read
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Femmie de VegtDepartment for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-8728-3397
Jessie J J GommersDepartment for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-6668-7819
Hans GroenewoudDepartment for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-4974-150X
Peter D SiersemaDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-6940-8499
André L M VerbeekDepartment for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-2319-5002
Yonne PetersDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-0789-097X
Mireille J M BroedersDepartment for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-8741-8148

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Western populations, the incidence of oesophageal squamous cell carcinoma (OSCC) has been declining, whereas the incidence of oesophageal adenocarcinoma (OAC) has been increasing. Our study examines temporal trends in the incidence of oesophageal cancer in the Netherlands between 1989 and 2016, in addition to predicting future trends through 2041. Data from the Netherlands Cancer Registry and Statistics Netherlands were collected to obtain incidence trends of OSCC and OAC for the period 1989 to 2016. Age-period-cohort (APC) modelling was used to estimate the contribution of age, calendar period and birth cohort on the observed incidence trends. To predict the future numbers of new cases of both OSCC and OAC from 2017 to 2041, log-linear APC models were fitted to the trends of 1989 to 2016. The age-standardised incidence rates of OSCC have decreased slightly for men and increased slightly for women. In contrast, a marked increase in the incidence of OAC was observed, ranging from 2.8 per 100 000 persons in 1989 to 10.1 in 2016. This increase in OAC incidence was more prominent in men, and it will result in an increased risk of OAC for successive generations. Future projections indicate that the incidence of OAC will further increase to 13.1 per 100 000 persons in 2037 to 2041, meaning that there will be 13 259 cases of OAC in 2037 to 2041, as compared to 9386 diagnoses in 2017 to 2021. The changing epidemiologic trends in oesophageal cancer in the Netherlands should be reflected in the development of prevention, early detection and treatment strategies.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overCohort StudiesEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleHumansIncidenceMaleMiddle AgedNetherlandsTime Factorsage-period-cohort modellingincidenceoesophageal adenocarcinomaoesophageal squamous cell carcinomatrends

Identifiers

PMID34605022
PMCPMC9292263

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.